Literature DB >> 19933925

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.

Gian Paolo Rossi1, Teresa Maria Seccia, Gaetana Palumbo, Anna Belfiore, Giampaolo Bernini, Graziella Caridi, Giovambattista Desideri, Bruno Fabris, Claudio Ferri, Gilberta Giacchetti, Claudio Letizia, Mauro Maccario, Francesca Mallamaci, Massimo Mannelli, Anna Patalano, Damiano Rizzoni, Ermanno Rossi, Achille Cesare Pessina, Franco Mantero.   

Abstract

The plasma aldosterone concentration:renin ratio (ARR) is widely used for the screening of primary aldosteronism, but its reproducibility is unknown. We, therefore, investigated the within-patient reproducibility of the ARR in a prospective multicenter study of consecutive hypertensive patients referred to specialized centers for hypertension in Italy. After the patients were carefully prepared from the pharmacological standpoint, the ARR was determined at baseline in 1136 patients and repeated after, on average, 4 weeks in the patients who had initially an ARR > or =40 and in 1 of every 4 of those with an ARR <40. The reproducibility of the ARR was assessed with Passing and Bablok and Deming regression, coefficient of reproducibility, and Bland-Altman and Mountain plots. Within-patient ARR comparison was available in 268 patients, of whom 49 had an aldosterone-producing adenoma, on the basis of the "4-corner criteria." The ARR showed a highly significant within-patient correlation (r=0.69; P<0.0001) and reproducibility. Bland-Altman plot showed no proportional, magnitude-related, or absolute systematic error between the ARR; moreover, only 7% of the values, for example, slightly more than what could be expected by chance, fell out of the 95% CI for the between-test difference. The accuracy of each ARR for pinpointing aldosterone-producing adenoma patients was approximately 80%. Thus, although it was performed under different conditions in a multicenter study, the ARR showed a good within-patient reproducibility. Hence, contrary to previously claimed poor reproducibility of the ARR, these data support its use for the screening of primary aldosteronism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933925     DOI: 10.1161/HYPERTENSIONAHA.109.139832

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.

Authors:  Giacomo Rossitto; Maurizio Cesari; Giulio Ceolotto; Giuseppe Maiolino; Teresa Maria Seccia; Gian Paolo Rossi
Journal:  J Hum Hypertens       Date:  2018-12-05       Impact factor: 3.012

Review 2.  Primary aldosteronism: A contrarian view.

Authors:  Norman M Kaplan
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 3.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 4.  Diagnosis and treatment of primary aldosteronism.

Authors:  Gian Paolo D Rossi
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 5.  Primary aldosteronism, diagnosis and treatment in Japan.

Authors:  Yoshiyu Takeda; Shigehoro Karashima; Takashi Yoneda
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 6.  Prevalence and diagnosis of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

7.  Clinical management of primary aldosteronism: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA).

Authors:  Gian Paolo Rossi; Anna Dalla Cà
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-25

Review 8.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

Review 9.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

10.  The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism.

Authors:  Gian Paolo Rossi; Valeria Bisogni
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.